Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-103.00	-354.29	-174.53
Graham Fair Price	-60.63	0.94	2.39
PEG	2933.01	1.58	-0.05
Price/Book	-41.39	4.42	7.54
Price/Cash Flow	-549.68	-1137.54	-175.09
Prices/Earnings	-478.32	-138.08	-23.88
Price/Sales	-44.89	57.06	103.53
Price/FCF	-549.68	-1137.54	-175.09
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-64.93	0.07	-0.20
Operating Margin	86.00	-0.18	-1.31
ROA	90.59	< 0.005	-0.05
ROE	-0.08	< 0.005	89.87
ROIC	-0.06	< 0.005	84.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	1.28	-0.05	2304.54
Dividends QOQ	-0.97	6.92	614.72
EBIT QOQ	-7.04	0.85	-87.90
EPS QOQ	-4.58	0.87	-80.93
FCF QOQ	-1.81	0.91	-49.77
Revenue QOQ	-0.62	0.05	-91.10
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	116.96	170.65	45.90
Days Sales Outstanding (DSO)	369.62	386.03	4.44
Inventory Turnover	0.77	0.53	-31.46
Debt/Capitalization	0.19	0.34	85.00
Quick Ratio	0.98	0.98	0.52
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.80	2.22	23.66
Cash	0.24	0.48	94.37
Capex	-0.07	-0.05	27.29
Free Cash Flow	-0.08	< 0.005	88.84
Revenue	0.13	0.17	31.49
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.39	1.36	-1.98
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.11	-23.21	-999.34
Naive Interpretation	Member

06 - Financial Health · Weak

Rating